A multicenter, open-label, comparative study of B-cell depletion therapy with Rituximab for systemic sclerosis-associated interstitial lung disease.
published in: Seminars in Arthritis and Rheumatism
date of publication: 2016-10-13
main subject: multicenter clinical trial, rituximab
Cites articles
There is nothing here
Article - wd:Q39191742